OCUGEN INC OCGN 深 滬
已收盤 05-08 16:00:00 美东时间
1.51
+0.070
+4.86%
華盛通- 最 高1.52
- 今 開1.50
- 成交量 1015.12万股
- 最 低 1.445
- 昨 收 1.44
- 總市值 5.11亿
- 52周最高 2.725
- 市盈率 靜 --
- 換手率 3.00%
- 52周最低 0.73
- 委 比 -50.53%
- 總股本 3.39亿
- 歷史最高 18.77
- 量 比 0.71
- 振 幅 5.21%
- 歷史最低 0.17
- 每 手 1
- 風險率 0.37%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Ocugen Advances Late-Stage Gene Therapies, Bolsters Cash Runway
Ocugen ( ($OCGN) ) just unveiled an announcement. Ocugen, Inc., based in Malver...
05-05 23:58
Ocugen stock dips as Q1 losses widen
Ocugen (OCGN) shares fell over 19% on Tuesday after the biotech’s net losses widened in Q1. Net loss for the quarter was $19.17M, compared to a $15.35M loss in the same period last year. The increased...
05-05 23:43
Full Transcript: Ocugen Q1 2026 Earnings Call
Ocugen (NASDAQ:OCGN) reported first-quarter financial results on Tuesday. The t...
05-05 23:11
Ocugen Q1 EPS $(0.06) Misses $(0.05) Estimate, Sales $1.533M Beat $540.000K Estimate
Ocugen (NASDAQ:OCGN) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.05) by 20 percent. This is a 20 percent decrease over losses of $(0.05) per share from the same
05-05 20:40
GeneDx Holdings, Duolingo, Kosmos Energy And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Dow futures up 100 pts. Shares of GeneDx Holdings (WGS) down 39.2% after cutting FY26 sales guidance. Other stocks falling in pre-market trading.
05-05 20:02
Earnings Scheduled For May 5, 2026
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
Ocugen Announces Private Convertible Notes Offering to Deleverage
An announcement from Ocugen ( ($OCGN) ) is now available. On May 4, 2026, Ocuge...
05-05 05:11
Ocugen issues $115M notes to repay debt; stock faces after-hours selling
Ocugen (OCGN) announced on Monday that it plans to raise about $115M through Convertible Senior Notes due 2034 in a private placement to qualified institutional buyers. Additionally, it also plans a 1...
05-05 04:27
Ocugen Plans To Commence $115M Senior Notes Offering
Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ:OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced its intention to offer, subject to market conditions and other factors,
05-05 04:24
